Trial intelligence / Profile preview

Nasal phenylephrine to prevent hypotension after spinal anesthesia

IRCT20240929063203N5Phase 3Recruiting

Sponsor
Hormozgan University of Medical Sciences
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of phenylephrine in hypotension, sponsored by Hormozgan University of Medical Sciences. Started Apr 2026; status: recruiting.

02

Drugs

phenylephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on IRCT20240929063203N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240929063203N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call